Tagged antibiotic-stewardship
Press Release
The Selux PBC Separator With Selux AST System Receives FDA 510(k) Clearance for Rapid Antibiotic Susceptibility Testing Direct From Positive Blood Culture
The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies. Read More
Press Release
Selux Diagnostics Receives FDA Clearance on Their Gram-Negative Panel, Expanding the Antibiotic Menu for Its Next Generation Phenotyping System for Rapid AST
Approval gives way to the most comprehensive single menu offered by an AST platform while delivering precise, rapid results in 5.5 hours from isolated colonies. Read More
Press Release
FDA Clears 'Selux NGP System' for Rapid Antibiotic Susceptibility Testing
In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic therapies Read More
Press Release
Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics' Clinical Advisory Board
Dr. Lewis, PharmD, FIDSA, is one of the preeminent experts in antibiotic stewardship and susceptibility testing (AST). He brings a wealth of knowledge to Selux as the company transforms infectious diseases clinical care and preserves the lifesaving power of antibiotics with its Next Generation Phenotyping (NGP) platform. Read More
Press Release